HeartSciences (HSCS) EPS (Basic) (2021 - 2026)
HeartSciences (HSCS) posted quarterly EPS (Basic) of -$1.05 for Q2 2026, up 52.98% year-on-year from -$0.69 in Q2 2025, and down 24.44% on a QoQ basis from -$0.85 in Q4 2025.
HeartSciences (HSCS) EPS (Basic) (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported EPS (Basic) for 6 consecutive years, with -$1.05 the latest figure, recorded in Q2 2026.
- Quarterly EPS (Basic) rose 52.98% year-over-year to -$1.05 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$8.55 (up 84.2% YoY) and the FY2026 annual result came in at -$9.81, up 60.62% from the prior year.
- EPS (Basic) retreated to -$1.05 in Q2 2026 per HSCS's latest filing, from -$0.85 in the prior quarter.
- Over the last five years, EPS (Basic) for HSCS reached as high as -$0.85 in Q4 2025 and fell as low as -$209.96 in Q3 2022.
- A 5-year average of -$58.49 and a median of -$20.53 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) plunged 825.15% — and 2025, when it soared 95.16%.
- Year by year, EPS (Basic) stood at -$152.77 in 2022, then climbed by 16.51% to -$127.54 in 2023, then soared by 86.29% to -$17.49 in 2024, then surged by 95.16% to -$0.85 in 2025, then decreased by 24.44% to -$1.05 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$1.05, -$0.85, and -$13.3 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - | -1.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.05 |
| Oct 31, 2025 | -0.85 |
| Jul 31, 2025 | -13.30 |
| Apr 30, 2025 | -2.24 |
| Jan 31, 2025 | -17.20 |
| Oct 31, 2024 | -17.49 |
| Jul 31, 2024 | -20.17 |
| Apr 30, 2024 | -5.39 |
| Jan 31, 2024 | -26.59 |
| Oct 31, 2023 | -127.54 |
| Jul 31, 2023 | -129.19 |
| Apr 30, 2023 | -20.53 |
| Jan 31, 2023 | -150.87 |
| Oct 31, 2022 | -152.77 |
| Jul 31, 2022 | -209.96 |
| Apr 30, 2022 | -61.91 |
| Jan 31, 2022 | -37.29 |
| Oct 31, 2021 | -31.23 |
| Jul 31, 2021 | -22.69 |